English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Oct 8, 2024

Baylor College faculty receive NIH awards for groundbreaking medical research
+ Pharmaceuticals
Patient Daily | Oct 8, 2024

Guidance offered for calm political discourse during election season
+ Pharmaceuticals
Patient Daily | Oct 8, 2024

Lung Association issues health guidance as Hurricane Milton approaches Florida
+ Pharmaceuticals
Patient Daily | Oct 7, 2024

UTHealth Houston administers new Alzheimer's drug Kisunla
+ Pharmaceuticals
Patient Daily | Oct 7, 2024

Folly Beach hosts LUNG FORCE Run/Walk on National Lung Cancer Screening Day
+ Pharmaceuticals
Patient Daily | Oct 7, 2024

Lung association issues health guidance ahead of Hurricane Milton
+ Pharmaceuticals
Patient Daily | Oct 4, 2024

American Lung Association advises on reducing health risks post-Hurricane Helene
+ Pharmaceuticals
Patient Daily | Oct 4, 2024

Americans show mixed reactions towards fall vaccines in new survey

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes